HPQ
HP Inc.
HPQ trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over HPQ overall, supported by stronger valuation and stronger fundamentals.
HPQ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
HPQ's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
HPQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.3x | $19.05 | -34% |
| Forward | 9.3x | $28.88 | — |
| Fair | 9.8x | $25.65 | -11% |
| Current | 11x | $28.88 | — |
| Expensive | 12x | $31.53 | +9.2% |
Historical ranges are pointers, not guarantees.
HPQ's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 9.3x next year's earnings, in its fair range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over HPQ in the historical PE scenario, which offers more potential upside but is not a forecast.
HPQ Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect HPQ's earnings to grow, with its revenue and profitability holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over HPQ on the outlook, with more favorable revenue and profitability expectations.
HPQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.11 | +19% |
| Q3 2026 | $2.62 | -4.4% |
| Q2 2026 | $2.71 | +4.6% |
| Q1 2026 | $2.64 | -5% |
| Q4 2025 | $2.65 | -5.7% |
| Q3 2025 | $2.74 | -3.9% |
| Q2 2025 | $2.59 | -13% |
| Q1 2025 | $2.78 | -19% |
| Q4 2024 | $2.81 | -15% |
HPQ's earnings per share have fallen from their peak: $2.62 over the past year, against $5.61 in mid-2022.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over HPQ on earnings, with more consistent year-over-year improvement.
HPQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $15.7B | +13% |
| Q2 2026 | $14.4B | +9% |
| Q1 2026 | $14.4B | +6.9% |
| Q4 2025 | $14.6B | +4.2% |
| Q3 2025 | $13.9B | +3.1% |
| Q2 2025 | $13.2B | +3.3% |
| Q1 2025 | $13.5B | +2.4% |
| Q4 2024 | $14.1B | +1.7% |
HPQ's revenue has grown year over year for nine quarters in a row: $15.7B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | +0.6 points |
| Q2 2026 | 4.3% | -0.7 points |
| Q1 2026 | 5.3% | -1 points |
| Q4 2025 | 6.5% | -0.5 points |
| Q3 2025 | 5.1% | -1.8 points |
| Q2 2025 | 5% | -2.5 points |
| Q1 2025 | 6.3% | -0.8 points |
| Q4 2024 | 7% | -0.3 points |
HPQ's operating margin was 5.7% last quarter, up 0.6 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over HPQ on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over HPQ on profitability, with a higher operating margin.
HPQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +7.1% |
| Q2 2026 | $756M | +$901M |
| Q1 2026 | $150M | +108% |
| Q4 2025 | $1.4B | -2.9% |
| Q3 2025 | $1.4B | +15% |
| Q2 2025 | -$145M | -131% |
| Q1 2025 | $72M | +$109M |
| Q4 2024 | $1.5B | -19% |
HPQ still generates free cash flow, though less than at its 2021 peak: $3.9B over the past year.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over HPQ on cash flow, with more consistent year-over-year improvement.
HPQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +2M shares |
| 1 year | -2.8% | -27M shares |
| 3 years | -7.5% | -75M shares |
| 5 years | -23% | -272M shares |
| Available history | -39% | -597M shares |
HPQ has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300M |
| Q2 2026 | $100M |
| Q1 2026 | $325M |
| Q4 2025 | $500M |
| Q3 2025 | $200M |
| Q2 2025 | $100M |
| Q1 2025 | $100M |
| Q4 2024 | $900M |
HPQ spent $1.2B buying back its own shares over the past year, down 5.8% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
HPQ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.4x | Healthy |
HPQ's net debt is about 1.2 years of its operating earnings (EBITDA), down from 1.6 years a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over HPQ on leverage, with a lower net debt burden relative to earnings.
HPQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 23.8 | Neutral |
HPQ's weekly RSI is 51 (neutral) and its Stochastic is 24 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
HPQ PE vs Technology Sector
| Metric | HPQ | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 60% below |
| PE % | 69 | 35 | 34 pts above |
HPQ is trading at 11x earnings, a 60% discount to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over HPQ on valuation relative to its sector.
HPQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.4 | 5.1% below |
| 20 week MA | $29.5 | 2.2% below |
| 50 week MA | $24.7 | 17% above |
| 100 week MA | $26.2 | 10% above |
| 200 week MA | $28.8 | 0.5% above |
HPQ has slipped below its 8- and 20-week averages, though it's still 0.5% above its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
HPQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.5 | $24.3 | +18% |
| 2021 | $24.3 | $37.7 | +55% |
| 2022 | $37.7 | $26.8 | -29% |
| 2023 | $26.8 | $30.1 | +12% |
| 2024 | $30.1 | $33.3 | +11% |
| 2025 | $33.3 | $23.3 | -30% |
| 2026 YTD | $23.3 | $28.9 | +24% |
HPQ has finished higher in four of the last six years. It's up 24% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over HPQ on returns for 2026, with the stronger performance.